 |
| Global Cerebral Angiography Market Size |
Cerebral angiography refers to a medical imaging technique used to visualize
blood vessels in the brain and neck. It involves the insertion of a catheter
into an artery, usually in the groin, and guiding it up into the arteries
supplying blood to the brain. A contrast agent is then injected through the
catheter and multiple X-ray images are taken to observe blood flow and to
detect any abnormalities. Cerebral angiography provides valuable information to
diagnose conditions such as aneurysms, arteriovenous malformations (AVMs),
clots, tumors and other vascular abnormalities. It allows for minimally
invasive treatment of these conditions through procedures such as aneurysm
coiling or bypass surgeries. The growing geriatric population who are more
susceptible to cerebrovascular diseases and the increasing preference for
minimally invasive procedures are major factors driving the demand for cerebral
angiography procedures.
The Global Cerebral Angiography Market is estimated to
be valued at US$ 17.24 Bn in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period
2024 to 2030.
Key Takeaways
Key players operating in the Cerebral Angiography are Kyowa Hakko Bio Co.,
Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., KOHJIN Life Sciences
Co., Ltd., Shenzhen GSH Bio-Technology Co, Ltd, Kaiping Genuine Biochemical
Pharmaceutical Co., Ltd., Nissor Pharmaceuticals Ltd., and Jarrow Formulas,
Inc. These companies are focusing on new product launches, facility expansions
and mergers and acquisitions to strengthen their market position. For instance,
in 2022 Kyowa Hakko Bio launched a new cerebral angiography catheter for
precise diagnosis of cerebrovascular diseases.
The rising incidences of cerebrovascular diseases and growing awareness about
early disease diagnosis present significant growth opportunities in the market.
According to statistics, over 17 million people suffer strokes worldwide each
year resulting in over 6 million deaths. Rising healthcare spending in
developing nations is also expected to drive the demand for cerebral
angiography procedures over the forecast period.
North America dominates the Global
Cerebral Angiography Market Size owing to advanced healthcare
infrastructure and high treatment rates. However, Asia Pacific is anticipated
to witness fastest growth during the forecast period driven by rapidly growing
economies, improving access to healthcare and increasing focus on diagnostic
services in countries such as India, China and Japan. Market players are
expanding their presence in emerging markets through partnerships and joint
ventures.
Market drivers
The significant driver propelling the growth of the cerebral angiography market
is the increasing geriatric population worldwide which is more prone to
cerebrovascular diseases. As per estimates, over 16% of the global population
will be aged over 65 years by 2050. Moreover, the rising prevalence of diseases
such as stroke, brain aneurysm and AVMs caused due to sedentary lifestyles and
escalating risk factors like obesity, diabetes and hypertension is driving the
need for accurate diagnosis and treatment planning using cerebral angiography
techniques.
Market restraints
The major restraint inhibiting the market growth is the high cost of cerebral
angiography procedures which makes them unaffordable for patients in low and
middle-income countries. In addition, cerebral angiography requires specialized
equipment, highly skilled physicians to perform the procedure which further
elevates the overall treatment cost. Lack of adequate reimbursement policies in
certain regions may also limit widespread adoption of this diagnostic
technique. Safety risks pertaining to radiation exposure from fluoroscopy and
use of iodinated contrast agents are some other challenges faced by the market.
Segment Analysis
The Cerebral Angiography Market can be segmented by Type into Magnetic
Resonance Angiography (MRA), Computed Tomography Angiography (CTA) and Digital
Subtraction Angiography (DSA). Of these, the DSA sub-segment dominates the
market currently due to the technique being considered as the gold standard for
detection of arterial anatomical details. DSA provides real-time imaging during
catheter angiography allowing interventional procedures to be performed during
the same setting.
Global Analysis
Regionally, North America holds the largest share in the Cerebral Angiography
Market owing to established healthcare infrastructure and significant awareness
among patients about cerebral disorders. The Asia Pacific region is anticipated
to be the fastest growing market over the forecast period due to rising
healthcare expenditure, increasing prevalence of cerebral indications and
growing medical tourism. Key players operating in the market include Kyowa
Hakko Bio Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd.,
KOHJIN Life Sciences Co., Ltd., Shenzhen GSH Bio-Technology Co, Ltd, Kaiping
Genuine Biochemical Pharmaceutical Co., Ltd., Nissor Pharmaceuticals Ltd., and
Jarrow Formulas, Inc.
Get More Insights On This Topic: Cerebral
Angiography Market
Explore More Article: Germany
Nutritional Supplements